Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Boehringer Ingelheim
Express Scripts
Mallinckrodt
McKinsey
McKesson
Farmers Insurance
Chubb
Covington
Argus Health

Generated: August 17, 2017

DrugPatentWatch Database Preview

Cholestyramine - Generic Drug Details

« Back to Dashboard

What are the generic sources for cholestyramine and what is the scope of cholestyramine patent protection?

Cholestyramine
is the generic ingredient in eight branded drugs marketed by Zydus Pharms Usa Inc, Par Pharm, Apothecon, Parke Davis, Bristol Myers, Teva, Ani Pharms Inc, Teva Pharms, Sandoz, Upsher-smith Labs, and Ivax Sub Teva Pharms, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for cholestyramine. Eight suppliers are listed for this compound.

Summary for Generic Name: cholestyramine

Tradenames:8
Patents:0
Applicants:11
NDAs:18
Drug Master File Entries: see list8
Suppliers / Packagers: see list8
Clinical Trials: see list21
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:cholestyramine at DailyMed

Pharmacology for Ingredient: cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071739-001May 26, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Teva Pharms
CHOLESTYRAMINE LIGHT
cholestyramine
POWDER;ORAL074555-002Sep 30, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Par Pharm
CHOLESTYRAMINE
cholestyramine
POWDER;ORAL077204-001Aug 26, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Sandoz
CHOLESTYRAMINE LIGHT
cholestyramine
POWDER;ORAL074558-001Aug 15, 1996ABRXNoYes► Subscribe► Subscribe► Subscribe
Upsher-smith Labs
PREVALITE
cholestyramine
POWDER;ORAL073263-002Oct 30, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: cholestyramine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071621-001May 26, 1988► Subscribe► Subscribe
Parke Davis
CHOLYBAR
cholestyramine
BAR, CHEWABLE;ORAL071739-001May 26, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Teva
Cerilliant
Fish and Richardson
Citi
Argus Health
Baxter
Farmers Insurance
Chinese Patent Office
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot